Jun 11, 2020
Sonny Hsiao, CEO, President, and Co-Founder Acepodia Biotech discusses how Acepodia is transforming the cell therapy landscape through a flexible and cost-effective platform that can be used to develop potent treatments for a broad range of indications. Sonny describes how they are applying this technology to enhance and energize immune cells with antibodies so that the immune cells can bind to tumor cells and overcome the challenges of treating solid tumors.
@acepodiainc
#CellTherapy #Antibody #AntibodyCellConjugation #CancerTherapy #CancerTreatment #oncology